샘플 요청 목록

 카트 문의
시장보고서
상품코드
1795989

세계의 페닐에프린 제제 시장

Phenylephrine Drugs
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 482 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

페닐에프린 제제 세계 시장은 2030년까지 330억 달러에 달할 전망

2024년에 229억 달러로 추정되는 페닐에프린 제제 세계 시장은 2024년부터 2030년까지 CAGR 6.3%로 성장하여 2030년에는 330억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 정제는 CAGR 7.0%를 기록하며 분석 기간 종료시에는 149억 달러에 달할 것으로 예측됩니다. 시럽제 부문의 성장률은 분석 기간 동안 CAGR 6.8%로 추정됩니다.

미국 시장은 62억 달러로 추정, 중국은 CAGR 10.0%로 성장 예측

미국의 페닐에프린 제제 시장은 2024년에 62억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 10.0%를 더듬어, 2030년까지 68억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.1%와 6.2%로 예측됩니다. 유럽에서는 독일이 CAGR 4.1%로 성장할 것으로 예측됩니다.

세계의 페닐에프린 제제 시장 - 주요 동향과 촉진요인 정리

페닐에프린은 오랫동안 시장에 존재해 왔음에도 불구하고 왜 다시 주목받고 있을까?

선택적 α1 아드레날린 수용체 작용제인 페닐에프린은 수십 년 동안 일반의약품(OTC) 및 처방약의 주성분으로 주로 코 충혈 완화제, 혈관압 강하제, 산동제로 사용되어 왔습니다. 그 매력은 혈관 수축 작용에 있으며, 코막힘을 해소하고, 저혈압 환자의 혈압을 높이고, 안과 검사를 쉽게 할 수 있습니다. 오랜 시장 역사에도 불구하고, 페닐에프린 제제는 진화하는 규제 당국의 움직임, 제형 혁신, 소매 및 병원 수요의 변화로 인해 시장에서의 위치가 재조명되고 있습니다.

규제 당국, 특히 미국 FDA가 경구용 페닐에프린의 코막힘 개선 효과에 의문을 제기한 것이 큰 전환점이 되었습니다. 이를 계기로 각 제조사들은 제형 개선의 물결을 타고 더 나은 생체 이용률을 제공하는 비강 스프레이, 점안액, 주사제 등 대체 투여 형태 개발에 박차를 가하고 있습니다. 병원에서는 특히 마취 및 패혈증성 쇼크 시 저혈압에 대한 속효성 혈관압 강하제로서 페닐에프린의 정맥 투여가 계속 신뢰받고 있으며, 임상적 의의가 지속되고 있습니다.

또한, 졸음을 유발하지 않는 감기약이나 독감 치료제로의 전환으로 인해 페닐에페드린은 슈도에페드린을 포함하지 않는 대안으로 유통되고 있습니다. 이 유효성분은 이비인후과, 안과, 중환자 치료 등의 용도에 적응할 수 있기 때문에 일반의약품의 관련성 변동에도 불구하고 폭넓은 시장 점유율을 유지하고 있습니다.

규제와 재제형화 추세는 제품 파이프라인을 어떻게 형성하고 있는가?

최근 규제 동향은 특히 경구용 충혈제거제 부문에서 페닐에프린의 포지셔닝에 큰 영향을 미치고 있습니다. 2023년 미국 FDA 자문위원회는 경구용 페닐에프린이 표준 OTC 용량으로는 효과가 없다는 결론을 내렸고, 라벨 개정과 제품 회수를 요구하는 목소리가 높아졌습니다. 페닐에프린을 주성분으로 하는 감기약을 다양한 브랜드명으로 판매하던 제약회사에서는 이 결과를 받아들여 제제 개선이 진행되고 있습니다.

이 개발은 OTC 영역에 도전이 되고 있지만, 동시에 간 대사를 우회하여 보다 효과적인 혈장 농도를 달성하는 비경구 및 비경구 제제로 업계의 초점이 이동하고 있습니다. 제약회사들은 페닐에프린과 코르티코스테로이드나 항히스타민제를 조합해 부비동을 완화하는 비강 점비제나 병용 비강내 요법을 점점 더 중요하게 여기고 있습니다. 이와 함께 제네릭 제약사들은 특히 수술실과 중환자실 관리 측면에서 병원 조달용 주사제 페닐에프린 생산을 강화하고 있습니다.

안과 영역에서 페닐에프린은 여전히 동공 확장의 표준 약물이며, 종종 트로피카미드와 함께 안약으로 점안합니다. 제형의 개선으로 보존성이 향상되고, 따끔거림이 감소하며, 주변 조건에서 안정성이 확보되고 있습니다. 이러한 발전은 규제된 임상 환경에서 페닐에프린의 수명주기를 연장하는 데 도움이 되고 있으며, 소비자 제제가 전환되고 있는 가운데서도 페닐에프린의 수명주기를 연장하는 데 도움이 되고 있습니다.

어떤 치료 분야와 세계 시장이 수요를 주도하고 있는가?

페닐에프린의 유용성은 호흡치료, 중환자 치료(혈관압박제), 안과 등 세 가지 핵심 치료 영역에 걸쳐 있습니다. 호흡기 영역에서는 작용 발현이 빠르고 전신 흡수가 적다는 점에서 비강 투여가 인기를 끌고 있습니다. 경구용 페닐에프린의 시장 점유율은 감소하고 있지만, 알레르기, 부비동염, 계절성 독감 시장에서는 비강 점안제 및 분무기의 수요가 비교적 안정적입니다.

병원 환경에서 페닐에프린 주사는 수술 전후 저혈압 및 패혈증성 쇼크 관리에 널리 사용되고 있습니다. 표준화된 마취 프로토콜에 포함되어 있고, 미리 채워진 주사기나 앰플을 통해 신속하게 사용할 수 있기 때문에 응급 의료 및 수술 관리에 필수적인 요소로 자리 잡았습니다. 신흥국의 입원율 증가와 ICU 확장으로 인해 무균 주사제 페닐에프린에 대한 수요가 더욱 증가하고 있습니다.

지역적으로는 북미가 병원 인프라 규모와 OTC 사용자 기반이 잘 구축되어 있어 우위를 점하고 있습니다. 유럽은 특히 안과 용도와 중증 치료 환경에서 근소한 차이로 그 뒤를 잇고 있습니다. 아시아태평양 시장에서는 국가 조달 프로그램, 의료 인프라 구축, 제네릭 제조업체의 현지 생산 확대에 따라 페닐에프린의 사용이 증가하고 있습니다. 인도와 중국 같은 국가도 주요 페닐에프린 원료의약품 공급국으로 부상하고 있으며, 세계 공급망과 가격 결정에 영향을 미치고 있습니다.

세계 페닐에프린 제제 시장의 성장을 주도하는 요인은 무엇인가?

페닐에프린 제제 세계 시장 성장의 원동력은 주사용 혈관압박제에 대한 병원 수요 증가, 안과용 약물 포트폴리오 확대, 비강 충혈제거제의 재제형화, 수술 및 중환자 치료 환경에서의 지속적 유용성 등입니다. 규제의 정밀한 조사는 OTC 상황을 재구성하고 있지만, 동시에 처방약과 시설에서 페닐에프린의 가치를 강화하고 있습니다.

병원 확장, 마취 중 저혈압 발생률 증가, 중환자실 입실 증가 등이 페닐에프린과 같은 신뢰할 수 있는 혈압 강하제에 대한 수요를 촉진하고 있습니다. 한편, 안과 검사 및 수술 시 동공확장제에 대한 지속적인 수요가 안과에서의 사용을 뒷받침하고 있습니다. 각 제조사들은 실용성을 높이기 위해 방부제 무첨가 단위 용량 바이알, 배합제 등 새로운 제형에 대응하고 있습니다.

또한, 페닐에프린의 원료의약품 생산 기반이 견고하고 비용 경쟁력이 있기 때문에 제제 제조업체는 시장 역학 변화에 신속하게 대응할 수 있습니다. 경구용 OTC 제품의 과제에도 불구하고, 이 원료의약품은 규제와 임상적 기대에 부응하는 형태로 재편되고 있습니다. 약물전달의 최적화와 중증 치료 의약품에 대한 세계 접근성에 대한 관심이 높아짐에 따라 페닐에프린 제제 시장은 지속적인 적응과 회복을 위한 준비를 하고 있습니다.

부문

유형(정제, 시럽, 점안제, 기타 유형), 적응증(감기 적응증, 코 충혈 제거 적응증, 알레르기 반응 적응증, 안질환 적응증, 기타 적응증), 투여 경로(경구 투여, 비경구 투여, 기타 투여 경로), 유통 채널(병원 약국, 드럭스토어·소매 약국, 온라인 유통 채널)

조사 대상 기업 사례

  • Aarti Pharmalabs Limited
  • Alembic Pharmaceuticals Ltd.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cadila Pharmaceuticals
  • Divi's Laboratories Limited
  • Dr. Reddy's Laboratories
  • Fagron Sterile Services
  • Foundation Consumer Brands LLC
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals plc
  • Merck & Co., Inc.
  • Mylan N.V.(Viatris)
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • Torrent Pharmaceuticals Inc.
  • Wockhardt Ltd.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.09.02

Global Phenylephrine Drugs Market to Reach US$33.0 Billion by 2030

The global market for Phenylephrine Drugs estimated at US$22.9 Billion in the year 2024, is expected to reach US$33.0 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Tablets, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$14.9 Billion by the end of the analysis period. Growth in the Syrup segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.2 Billion While China is Forecast to Grow at 10.0% CAGR

The Phenylephrine Drugs market in the U.S. is estimated at US$6.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Phenylephrine Drugs Market - Key Trends & Drivers Summarized

Why Is Phenylephrine Seeing Renewed Interest Despite Its Longstanding Market Presence?

Phenylephrine, a selective α1-adrenergic receptor agonist, has been a mainstay in over-the-counter (OTC) and prescription drugs for decades, primarily used as a nasal decongestant, vasopressor, and mydriatic agent. Its appeal lies in its vasoconstrictive properties, which enable it to relieve nasal congestion, raise blood pressure in hypotensive patients, and facilitate ophthalmic examinations. Despite its long market history, phenylephrine drugs are undergoing renewed scrutiny and market repositioning due to evolving regulatory actions, formulation innovations, and demand shifts in both retail and hospital settings.

A major inflection point occurred when regulatory bodies, particularly the U.S. FDA, questioned the efficacy of orally administered phenylephrine for nasal decongestion. This has triggered a wave of reformulation activity among manufacturers and catalyzed the development of alternative delivery formats, such as intranasal sprays, ophthalmic solutions, and injectable formulations that offer better bioavailability. Hospitals continue to rely on intravenous phenylephrine as a fast-acting vasopressor for hypotension, especially during anesthesia or septic shock, ensuring sustained clinical relevance.

Additionally, the shift toward non-drowsy cold and flu medications has kept phenylephrine in circulation as a pseudoephedrine-free option, especially in regions where regulatory restrictions on pseudoephedrine sales remain stringent. The active ingredient's adaptability across ENT, ophthalmic, and critical care applications helps maintain a broad market footprint, despite fluctuating OTC relevance.

How Are Regulatory and Reformulation Trends Reshaping Product Pipelines?

Recent regulatory developments have deeply impacted the positioning of phenylephrine, particularly in the oral decongestant segment. A U.S. FDA advisory panel in 2023 concluded that oral phenylephrine is ineffective at standard OTC doses, sparking calls for label revisions and product withdrawals. This finding is driving a reformulation push among pharmaceutical companies that had previously marketed phenylephrine-based cold medications under various brand names.

While this development challenges the OTC space, it is also redirecting industry focus toward intranasal and parenteral formulations that bypass hepatic metabolism and achieve more effective plasma concentrations. Pharmaceutical companies are increasingly emphasizing nasal sprays and combination intranasal therapies that pair phenylephrine with corticosteroids or antihistamines for dual-action sinus relief. In parallel, generic drug makers are ramping up production of injectable phenylephrine for hospital procurement, especially in the context of operating room and ICU management.

In ophthalmology, phenylephrine remains a gold-standard agent for pupil dilation, often paired with tropicamide in combination drops. Formulation improvements are enhancing shelf life, reducing stinging sensation, and ensuring stability under ambient conditions. These advances are helping extend phenylephrine’s lifecycle in regulated clinical settings, even as its consumer-facing formulations undergo transition.

Which Therapeutic Segments and Global Markets Are Driving Demand?

Phenylephrine's utility spans three core therapeutic domains: respiratory care, critical care (vasopressors), and ophthalmology. In respiratory care, the intranasal segment is gaining traction due to fast onset of action and minimal systemic absorption. Despite the erosion of oral phenylephrine’s market share, demand remains relatively stable for nasal sprays and nebulized solutions in allergy, sinusitis, and seasonal flu markets.

In hospital settings, phenylephrine injections are widely used for managing perioperative hypotension and septic shock. Their inclusion in standardized anesthesia protocols, combined with rapid availability in prefilled syringes and ampoules, makes them a critical component of emergency care and surgical management. Increased hospitalization rates and ICU expansions in emerging economies are further boosting demand for sterile injectable phenylephrine.

Geographically, North America dominates due to the scale of hospital infrastructure and the established base of OTC users. Europe follows closely, especially in ophthalmic applications and critical care settings. Asia-Pacific markets are witnessing growth in phenylephrine use through national procurement programs, rising healthcare infrastructure, and expanded local production by generic manufacturers. Countries like India and China are also becoming major phenylephrine API suppliers, influencing global supply chains and pricing.

What Is Driving Growth in the Global Phenylephrine Drugs Market?

The growth in the global phenylephrine drugs market is driven by increasing hospital demand for injectable vasopressors, expanding ophthalmic drug portfolios, reformulation of nasal decongestants, and sustained utility in surgical and critical care environments. While regulatory scrutiny is reshaping the OTC landscape, it is simultaneously reinforcing phenylephrine’s value in prescription and institutional settings.

Hospital expansions, growing rates of hypotensive episodes during anesthesia, and rising ICU admissions are fueling demand for reliable vasopressors like phenylephrine. Meanwhile, continued demand for pupil-dilating agents in eye exams and surgeries is sustaining its use in ophthalmology. Manufacturers are responding with new formats such as preservative-free, unit-dose vials and combination formulations for enhanced utility.

Additionally, the API manufacturing base for phenylephrine is strong and cost-competitive, allowing formulators to adapt quickly to changing market dynamics. Despite challenges in oral OTC products, the active pharmaceutical ingredient is being repositioned across formats that meet both regulatory and clinical expectations. With a growing focus on drug delivery optimization and global access to critical care drugs, the phenylephrine drugs market is poised for continued adaptation and resilience.

SCOPE OF STUDY:

The report analyzes the Phenylephrine Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Tablets, Syrup, Eye Drops, Other Types); Indication (Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication, Other Indications); Administration Route (Oral Administration, Parenteral Administration, Other Administration Routes); Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Aarti Pharmalabs Limited
  • Alembic Pharmaceuticals Ltd.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cadila Pharmaceuticals
  • Divi's Laboratories Limited
  • Dr. Reddy's Laboratories
  • Fagron Sterile Services
  • Foundation Consumer Brands LLC
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals plc
  • Merck & Co., Inc.
  • Mylan N.V. (Viatris)
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • Torrent Pharmaceuticals Inc.
  • Wockhardt Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Phenylephrine Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Regulatory Scrutiny Over Oral Decongestants Throws the Spotlight On Phenylephrine Formulations
    • Shifting Clinical Preferences Toward Safer Nasal Agents Drives Demand for Topical Phenylephrine
    • Increased Incidence of Allergic Rhinitis and Sinusitis Spurs Use of Sympathomimetic Agents
    • Rising OTC Sales of Cold and Flu Remedies Expands Addressable Market for Phenylephrine-Based Products
    • Debate Over Oral Bioavailability Strengthens Business Case for Reformulated and Nasal Delivery Formats
    • Surge in Pediatric Respiratory Infections Drives Use of Low-Dose Phenylephrine Syrups
    • Stringent FDA and EMA Guidelines on Efficacy Drive R&D in Improved Phenylephrine Delivery Systems
    • Growing Availability of Combination Therapy Products Enhances Market Penetration
    • Hospital Demand for Hemodynamic Stabilization Agents Spurs Use of Injectable Phenylephrine
    • Public Health Campaigns Around Self-Medication Increase Demand for Non-Prescription Decongestants
    • Increased Generic Competition Creates Pressure on Pricing and Innovation in Differentiated Formulations
    • Expansion of E-Commerce and D2C Pharmacies Drives Online Sales of Phenylephrine Products
    • Seasonal Demand Spikes During Allergy and Flu Seasons Sustain Growth in Decongestant Categories
    • Reformulation of Cough-Cold Products in Response to Regulatory Reviews Drives Product Redevelopment
    • Increased Focus on Abuse-Deterrent Formulations Promotes Safer Phenylephrine Combinations
    • Rising Demand for Single-Ingredient Nasal Sprays Fuels Product Line Diversification
    • Emergence of Novel Nasal Delivery Technologies Enhances Targeted Therapeutic Efficiency
    • Clinical Use in Managing Hypotension During Anesthesia Expands Hospital Market Opportunity
    • Regional Differences in Regulatory Classifications Create Market Entry Challenges and Opportunities
    • Increased Healthcare Provider Education on Dosing and Efficacy Supports Informed Prescribing Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Phenylephrine Drugs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Phenylephrine Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Syrup by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Syrup by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Syrup by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Eye Drops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Eye Drops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Eye Drops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Drug Stores & Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Drug Stores & Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Drug Stores & Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Cold Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Cold Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Cold Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Nasal Decongestion Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Nasal Decongestion Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Nasal Decongestion Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Allergic Reaction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Allergic Reaction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Allergic Reaction Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Eye Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Eye Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Eye Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Canada 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • JAPAN
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Japan 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • CHINA
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 86: China Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: China 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: China 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: China 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: China 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • EUROPE
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Phenylephrine Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • FRANCE
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 113: France Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: France 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: France 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: France 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: France 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • GERMANY
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Germany 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Germany 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Germany 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Italy 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Italy 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Italy 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Italy 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 149: UK Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: UK 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: UK 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 155: UK Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: UK 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: UK 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Spain 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Spain 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Spain 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Spain 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Russia 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Russia 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Russia 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Russia 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Phenylephrine Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Australia 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Australia 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Australia 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Australia 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • INDIA
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 224: India Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: India 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: India 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 230: India Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: India 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: India 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: South Korea 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: South Korea 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: South Korea 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: South Korea 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Phenylephrine Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Latin America 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Latin America 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Latin America 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Latin America 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Latin America 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Argentina 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Argentina 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Argentina 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Argentina 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Brazil 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Brazil 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Brazil 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Brazil 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Mexico 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Mexico 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Mexico 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Mexico 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Phenylephrine Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 325: Middle East 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 328: Middle East 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 331: Middle East 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 334: Middle East 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 337: Middle East 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 340: Iran 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 343: Iran 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 346: Iran 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 349: Iran 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 352: Israel 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 355: Israel 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 358: Israel 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 361: Israel 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 376: UAE 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 379: UAE 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 382: UAE 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 385: UAE 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
  • AFRICA
    • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 400: Africa 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 403: Africa 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 406: Africa 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 409: Africa 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제